A medical and aesthetic clinic in Al Barsha 1 with a first-party page advertising broad peptide-therapy protocols.
Availability does not establish approval or effectiveness. Ask for the exact active ingredient, product registration, indication, prescriber, dispensing source, risks, alternatives, and follow-up plan.
The clinic names approved peptide-based medicines alongside experimental compounds on the same service page. Approval and evidence must be checked separately for each exact product, indication, and formulation.
Dynamic Life Clinics publicly lists peptide-treatment prices from AED 1,099 to AED 2,499.
These are clinic-stated figures. The clinic says final treatment cost follows assessment; confirm the exact product, inclusions, VAT, monitoring and follow-up directly.
Price information is attributed to the clinic and may change. It does not establish medical approval, product registration, effectiveness or the total cost of care.
These labels assess the named molecule, not the clinic’s particular product, protocol or marketing claim. UAE registration remains product and indication specific.
| Peptide | Category | Evidence | Approval note | Editorial assessment |
|---|---|---|---|---|
| BPC-157 | Experimental compound | Preclinical | Not established as an approved human medicine | Most supportive claims rely on laboratory or animal research; robust clinical evidence and established approval are lacking. |
| CJC-1295 | Experimental compound | Limited | Not established as an approved human medicine | Small human studies do not establish broad wellness, anti-ageing or body-composition claims. |
| GHK-Cu | Experimental compound | Limited | Depends on formulation and intended use | Cosmetic ingredient use is different from injected or systemic treatment claims. Evidence and regulation depend on formulation. |
| Ipamorelin | Experimental compound | Limited | Not established as an approved human medicine | Human evidence is limited and does not establish the broad outcomes commonly promoted by clinics. |
| Semaglutide | Prescription medicine | High | Product and indication specific | Supported by substantial human evidence for specific approved metabolic indications. Verify the exact UAE-registered brand and intended use. |
| Tesamorelin | Prescription medicine | High | Approval is jurisdiction and indication specific | A prescription medicine in some jurisdictions for a narrow indication. That does not establish UAE registration or other uses. |
| Thymosin Beta-4 | Experimental compound | Limited | Exact product and use require verification | Research on thymosin beta-4 should not be treated as evidence for every product marketed as TB-500 or for broad recovery claims. |
Confirm current hours with the clinic
+971 4 388 8504Compare clinical assessment, product traceability, informed consent, monitoring, adverse-event support, and alternatives—not marketing claims.
Is this information outdated? Send the editorial team a correction.Clinics cannot pay to change directory order or evidence classifications.